FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980115463> ?p ?o ?g. }

• W2980115463 endingPage "S614" @default.
• W2980115463 startingPage "S613" @default.
• W2980115463 abstract "INTRODUCTION: Injection drug use [IDU] is a well-known risk factor for both infective endocarditis [IE] and hepatitis C virus [HCV] infections. In parallel with the opioid epidemic, the incidence of both infections has increased in recent years. In this retrospective study, the impact of HCV on mortality of people who inject drugs [PWID] with IE is assessed. METHODS: Electronic medical records of adult patients diagnosed with IE according to modified Duke criteria from January 2012 through May 2018 at an academic tertiary medical center were analyzed. Patients were identified as PWID based on IDU documentation within 3 months of admission. The study included all patients with a positive HCV antibody. Patients were then stratified into two groups: “Positive HCV viremia” [positive HCV antibody and viral load] or “Negative HCV viremia” [positive HCV antibody but negative viral load]. Prior HCV treatment, HIV infection, and absence of documented HCV seropositivity precluded study enrollment. Pertinent demographic, clinical, laboratory, microbiologic, and outcome data were recorded and analyzed. RESULTS: One hundred and twenty-nine PWID with IE were identified, of whom 110 [85.2%] had a positive HCV antibody. Of these, 23 patients were excluded due to lack of testing for viral RNA. , resulting in 87 HCV study patients [67.4%]. Fifty-three [61.0%] patients had viremia and 34 [39.1%] did not. Of the 87 study patients, 85.1% were Caucasian and 52.9% were female with a median age of 25. Six [6.9%] patients had previous IE. The most commonly injected drug was prescription opioids [69.0%]. The tricuspid valve was involved in 56.3% of patients and the most common pathogen was Staphylococcus aureus [71.3%]. Prescription opioid injection, S. aureus infection, tricuspid valve involvement, and 10-week mortality did not differ between the viremic and non-viremic HCV groups [Table 1]. CONCLUSION: While several host and clinical factors affect mortality in PWID with IE, HCV viremia does not appear to increase mortality. However, larger, prospective studies will be required to better delineate the significance of HCV viremia among PWID with IE." @default.
• W2980115463 created "2019-10-18" @default.
• W2980115463 creator A5009414419 @default.
• W2980115463 creator A5011374275 @default.
• W2980115463 creator A5012386935 @default.
• W2980115463 creator A5054929494 @default.
• W2980115463 creator A5071271485 @default.
• W2980115463 creator A5082810782 @default.
• W2980115463 date "2019-10-01" @default.
• W2980115463 modified "2023-10-16" @default.
• W2980115463 title "1084 Does Viremia in Patients With Hepatitis C Antibody Positivity Alter Mortality in People Who Inject Drugs With Infective Endocarditis?" @default.
• W2980115463 doi "https://doi.org/10.14309/01.ajg.0000593868.74956.c7" @default.
• W2980115463 hasPublicationYear "2019" @default.
• W2980115463 type Work @default.
• W2980115463 sameAs 2980115463 @default.
• W2980115463 citedByCount "0" @default.
• W2980115463 crossrefType "journal-article" @default.
• W2980115463 hasAuthorship W2980115463A5009414419 @default.
• W2980115463 hasAuthorship W2980115463A5011374275 @default.
• W2980115463 hasAuthorship W2980115463A5012386935 @default.
• W2980115463 hasAuthorship W2980115463A5054929494 @default.
• W2980115463 hasAuthorship W2980115463A5071271485 @default.
• W2980115463 hasAuthorship W2980115463A5082810782 @default.
• W2980115463 hasConcept C120665830 @default.
• W2980115463 hasConcept C121332964 @default.
• W2980115463 hasConcept C126322002 @default.
• W2980115463 hasConcept C142462285 @default.
• W2980115463 hasConcept C159654299 @default.
• W2980115463 hasConcept C203014093 @default.
• W2980115463 hasConcept C2522874641 @default.
• W2980115463 hasConcept C2776185481 @default.
• W2980115463 hasConcept C2776408679 @default.
• W2980115463 hasConcept C2776455275 @default.
• W2980115463 hasConcept C61511704 @default.
• W2980115463 hasConcept C71924100 @default.
• W2980115463 hasConcept C90924648 @default.
• W2980115463 hasConceptScore W2980115463C120665830 @default.
• W2980115463 hasConceptScore W2980115463C121332964 @default.
• W2980115463 hasConceptScore W2980115463C126322002 @default.
• W2980115463 hasConceptScore W2980115463C142462285 @default.
• W2980115463 hasConceptScore W2980115463C159654299 @default.
• W2980115463 hasConceptScore W2980115463C203014093 @default.
• W2980115463 hasConceptScore W2980115463C2522874641 @default.
• W2980115463 hasConceptScore W2980115463C2776185481 @default.
• W2980115463 hasConceptScore W2980115463C2776408679 @default.
• W2980115463 hasConceptScore W2980115463C2776455275 @default.
• W2980115463 hasConceptScore W2980115463C61511704 @default.
• W2980115463 hasConceptScore W2980115463C71924100 @default.
• W2980115463 hasConceptScore W2980115463C90924648 @default.
• W2980115463 hasIssue "1" @default.
• W2980115463 hasLocation W29801154631 @default.
• W2980115463 hasOpenAccess W2980115463 @default.
• W2980115463 hasPrimaryLocation W29801154631 @default.
• W2980115463 hasRelatedWork W1826357082 @default.
• W2980115463 hasRelatedWork W1872883352 @default.
• W2980115463 hasRelatedWork W1973675133 @default.
• W2980115463 hasRelatedWork W1980716852 @default.
• W2980115463 hasRelatedWork W2062591279 @default.
• W2980115463 hasRelatedWork W2167035059 @default.
• W2980115463 hasRelatedWork W2222120230 @default.
• W2980115463 hasRelatedWork W2319430326 @default.
• W2980115463 hasRelatedWork W2795472922 @default.
• W2980115463 hasRelatedWork W3204972944 @default.
• W2980115463 hasVolume "114" @default.
• W2980115463 isParatext "false" @default.
• W2980115463 isRetracted "false" @default.
• W2980115463 magId "2980115463" @default.
• W2980115463 workType "article" @default.